Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × Aprepitant × Clear all

NCT02646020 2021-05-18

EGFR-TKIs

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Pruritus

NCT02407600 2015-04-03

Study Assessing Fosaprepitant in Advanced NSCLC Patients Treated With Carboplatin Based Chemotherapy

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Nausea, Vomiting